PATENT CLAIM ANALYSIS

Application Number: 16067097
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["540", "575000"]

Abstract:
The present invention discloses a compound shown in formula I or a stereoisomer, pharmaceutically acceptable salt, crystal form, solvate or isotopologue thereof. The compound of the present invention shows excellent inhibition activity against histone deacetylases, has remarkable inhibition effects on cancer cells, and provides a new choice of drugs used for the clinic treatment and diseases related to the abnormal activity of histone deacetylases.

Claim (Index 39):
A method for treating and/or preventing cell proliferation disorder diseases, autoimmune diseases, inflammations, neurodegenerative diseases or viral diseases, comprising administering to a patient in need thereof the compound or a stereoisomer, pharmaceutically acceptable salt, crystal form, solvate or isotopologue thereof according to  claim 1 .

Metadata:
- Claim Count in Document: 54.0
- Percentile: 94.0
- Lexical Diversity: 1.42
- Patent Class: 540.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15635181', '15718474', '14377616', '10143335', '14763468']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6443091856045907
- 35 USC 102 Novelty (BERT): 0.521223068336679
- Combined Prediction Score: 0.6320005738777996
- Mean Citation Score: 272.53179600000004
- Max Citation Score: 295.58173
- Similarity Product: 220.96342915391085

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test